Logo image of PSNL

PERSONALIS INC (PSNL) Stock Fundamental Analysis

NASDAQ:PSNL - Nasdaq - US71535D1063 - Common Stock

5.55  +0.66 (+13.5%)

Premarket: 5.7 +0.15 (+2.7%)

Fundamental Rating

2

Taking everything into account, PSNL scores 2 out of 10 in our fundamental rating. PSNL was compared to 56 industry peers in the Life Sciences Tools & Services industry. The financial health of PSNL is average, but there are quite some concerns on its profitability. While showing a medium growth rate, PSNL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PSNL had negative earnings in the past year.
In the past year PSNL has reported a negative cash flow from operations.
In the past 5 years PSNL always reported negative net income.
PSNL had a negative operating cash flow in each of the past 5 years.
PSNL Yearly Net Income VS EBIT VS OCF VS FCFPSNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -38.12%, PSNL is doing worse than 78.57% of the companies in the same industry.
PSNL has a worse Return On Equity (-54.83%) than 66.07% of its industry peers.
Industry RankSector Rank
ROA -38.12%
ROE -54.83%
ROIC N/A
ROA(3y)-34.43%
ROA(5y)-27.22%
ROE(3y)-52.21%
ROE(5y)-40.27%
ROIC(3y)N/A
ROIC(5y)N/A
PSNL Yearly ROA, ROE, ROICPSNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

1.3 Margins

PSNL's Gross Margin of 31.41% is on the low side compared to the rest of the industry. PSNL is outperformed by 67.86% of its industry peers.
In the last couple of years the Gross Margin of PSNL has declined.
PSNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-4.55%
PSNL Yearly Profit, Operating, Gross MarginsPSNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200 -250

More info and screens

4

2. Health

2.1 Basic Checks

PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PSNL has been increased compared to 1 year ago.
PSNL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PSNL is higher compared to a year ago.
PSNL Yearly Shares OutstandingPSNL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
PSNL Yearly Total Debt VS Total AssetsPSNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

PSNL has an Altman-Z score of 0.81. This is a bad value and indicates that PSNL is not financially healthy and even has some risk of bankruptcy.
PSNL has a worse Altman-Z score (0.81) than 67.86% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PSNL is not too dependend on debt financing.
The Debt to Equity ratio of PSNL (0.00) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACCN/A
WACC10.62%
PSNL Yearly LT Debt VS Equity VS FCFPSNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.68 indicates that PSNL has no problem at all paying its short term obligations.
The Current ratio of PSNL (4.68) is better than 69.64% of its industry peers.
PSNL has a Quick Ratio of 4.44. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
PSNL has a better Quick ratio (4.44) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.44
PSNL Yearly Current Assets VS Current LiabilitesPSNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.66% over the past year.
Looking at the last year, PSNL shows a very strong growth in Revenue. The Revenue has grown by 24.05%.
Measured over the past years, PSNL shows a quite strong growth in Revenue. The Revenue has been growing by 14.24% on average per year.
EPS 1Y (TTM)25.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)24.05%
Revenue growth 3Y-2.24%
Revenue growth 5Y14.24%
Sales Q2Q%40.89%

3.2 Future

Based on estimates for the next years, PSNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.40% on average per year.
Based on estimates for the next years, PSNL will show a very strong growth in Revenue. The Revenue will grow by 38.19% on average per year.
EPS Next Y30.48%
EPS Next 2Y21.61%
EPS Next 3Y16.67%
EPS Next 5Y17.4%
Revenue Next Year13.61%
Revenue Next 2Y9.17%
Revenue Next 3Y18.63%
Revenue Next 5Y38.19%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSNL Yearly Revenue VS EstimatesPSNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
PSNL Yearly EPS VS EstimatesPSNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNL Price Earnings VS Forward Price EarningsPSNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNL Per share dataPSNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PSNL's earnings are expected to grow with 16.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.61%
EPS Next 3Y16.67%

More info and screens

0

5. Dividend

5.1 Amount

PSNL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERSONALIS INC

NASDAQ:PSNL (1/21/2025, 8:22:01 PM)

Premarket: 5.7 +0.15 (+2.7%)

5.55

+0.66 (+13.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners53.06%
Inst Owner Change-0.13%
Ins Owners1.67%
Ins Owner Change90.16%
Market Cap470.03M
Analysts81.67
Price Target7.8 (40.54%)
Short Float %6.12%
Short Ratio2.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.15%
Min EPS beat(2)-79.27%
Max EPS beat(2)36.97%
EPS beat(4)2
Avg EPS beat(4)-2.72%
Min EPS beat(4)-79.27%
Max EPS beat(4)37.32%
EPS beat(8)4
Avg EPS beat(8)0.35%
EPS beat(12)7
Avg EPS beat(12)2.11%
EPS beat(16)10
Avg EPS beat(16)3.16%
Revenue beat(2)2
Avg Revenue beat(2)16.56%
Min Revenue beat(2)14.93%
Max Revenue beat(2)18.2%
Revenue beat(4)3
Avg Revenue beat(4)8.77%
Min Revenue beat(4)-2.3%
Max Revenue beat(4)18.2%
Revenue beat(8)6
Avg Revenue beat(8)6.64%
Revenue beat(12)9
Avg Revenue beat(12)6.46%
Revenue beat(16)11
Avg Revenue beat(16)4.66%
PT rev (1m)8.51%
PT rev (3m)8.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)21.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.37
P/FCF N/A
P/OCF N/A
P/B 2.82
P/tB 2.82
EV/EBITDA N/A
EPS(TTM)-1.68
EYN/A
EPS(NY)-1.11
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS1.03
BVpS1.97
TBVpS1.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.12%
ROE -54.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.41%
FCFM N/A
ROA(3y)-34.43%
ROA(5y)-27.22%
ROE(3y)-52.21%
ROE(5y)-40.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-4.55%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.31%
Cap/Sales 4.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.44
Altman-Z 0.81
F-Score5
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)290.96%
Cap/Depr(5y)221.15%
Cap/Sales(3y)34.84%
Cap/Sales(5y)24.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y30.48%
EPS Next 2Y21.61%
EPS Next 3Y16.67%
EPS Next 5Y17.4%
Revenue 1Y (TTM)24.05%
Revenue growth 3Y-2.24%
Revenue growth 5Y14.24%
Sales Q2Q%40.89%
Revenue Next Year13.61%
Revenue Next 2Y9.17%
Revenue Next 3Y18.63%
Revenue Next 5Y38.19%
EBIT growth 1Y35.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.66%
EBIT Next 3Y11.53%
EBIT Next 5YN/A
FCF growth 1Y51.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.15%
OCF growth 3YN/A
OCF growth 5YN/A